Chengdu Science and Technology Venture Capital
VC Fund
Chengdu, China
Chengdu Science and Technology Venture Capital is a VC fund in Chengdu focused on Manufacturing and Medical. Chengdu Science and Technology Venture Capital Group is a venture capital firm that promotes the local transformation of scientific and technological achievements.
- Total investments:
- 65
- Last investment:
- Lead investor:
- 35%
Last updated:
For AI agents: llms.txt
Industries Chengdu Science and Technology Venture Capital invests in
Stages Chengdu Science and Technology Venture Capital invests in
Countries Chengdu Science and Technology Venture Capital invests in
Round sizes
Round size
- Seed
- $12M–$41M
- Series A
- $14M–$147M
- Series B
- $14M–$147M
Investment Focus
Industry
- Manufacturing 20 (31%)
- Medical 9 (14%)
- Semiconductor 8 (12%)
- Aerospace 6 (9%)
- Biotechnology 6 (9%)
Stage
- Series A 15 (23%)
- Series B 11 (17%)
- Seed 10 (15%)
- Series C 6 (9%)
- Venture - Series Unknown 4 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
ClonOrgan has developed a technology to humanize pig cells that will grow into human-compatible organs.The business specializes in xenotransplantation and has a one-stop R&D platform that includes raising gene-edited pigs, preclinical testing, and breeding. It is dedicated to addressing the critical shortage of clinical organ transplantationand creating the organ factory of the future.ClonOrgas was established in 2005 in Chengdu, Sichuan. | Series A / Aug 07, 2026 | |
|
|
Guangna Siwei is an optoelectronic device seller. | $29.6M / Venture - Series Unknown / Aug 05, 2026 | |
|
|
Blue Wave is a producer of Industrial IoT and Internet of Vehicles chips. | Series A / Aug 01, 2026 | |
|
Yuxi Semiconductor
|
Yuxi Semiconductor is a manufacturing company that provides microwave chips and gallium nitride-based power amplifier chips. | Series A / Jul 24, 2026 | |
|
|
VAST is an artificial intelligence business that develops and manufactures general-purpose 3D big models. Its goal is to develop a popular 3D content production tool, a 3D user-generated content platform, and utilize 3D space to enhance user experience. | $147.3M / Series A / Jul 02, 2026 | |
|
|
iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases. | $38.3M / Series C / Jul 02, 2026 | |
|
|
Vistar Optoelectronics is a provider of micro-LED displays that focuses on the research, development, and product implementation of micro-LED. | Series B / Jul 01, 2026 | |
|
|
DexForce offers an AI-enabled robot with integrated 3D vision cameras, and software and hardware solutions for manufacturing robots. | $147.3M / Series B / Jun 30, 2026 | |
|
|
Heyuan Lithium is a company that manufacturers solid-state lithium-ion battery. The company specializes in the research and development, manufacture, and distribution of solid-state lithium-ion battery products, with a focus on high-energy-density, high-safety, long-life solid-state cells and solid-state battery products for energy storage, powergeneration, and household appliances. It is dedicated to making batteries safer, greener, more convenient, and long-lasting for human intellectual existence. | Series A / Jun 25, 2026 | |
|
|
Yunji Avionics is an avionics system solution provider specializing in the development of avionics systems for the low-altitude economy sector. It focuses on providing cutting-edge avionics equipment and solutions for low-altitude aircraft, offering integrated, intelligent avionics systems that enhance safety and stability. | Seed / Jun 24, 2026 | |
| See all 65 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Chengdu Science and Technology Venture Capital invest in?
Chengdu Science and Technology Venture Capital invests primarily in Manufacturing, Medical and Semiconductor startups, most often at Series A and Series B stage. Most of the 65 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Chengdu Science and Technology Venture Capital's check size?
Chengdu Science and Technology Venture Capital typically joins rounds of $12M–$41M at Seed, $14M–$147M at Series A and $14M–$147M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chengdu Science and Technology Venture Capital participates in.
When did Chengdu Science and Technology Venture Capital last invest?
The most recent investment recorded for Chengdu Science and Technology Venture Capital closed in Aug 2026. Shizune tracks 65 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!